Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India

British Journal of Ophthalmology

Volumn 93, Issue 1, 2009, Pages 88-90

  Shah, S U ^a,b   Kerkar, S P ^a   Pazare, A R ^a  

^a KEM HOSPITAL   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS PATIENT; ARTICLE; BLINDNESS; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; EYE DISEASE; EYE EXAMINATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INDIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINITIS; RETINOPATHY; TERTIARY HEALTH CARE; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLINDNESS; CD4 LYMPHOCYTE COUNT; CHILD; CROSS-SECTIONAL STUDIES; EYE INFECTIONS, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; RETINAL DISEASES; VIRAL LOAD; YOUNG ADULT;

EID: 58349094933     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.149237     Document Type: Article

References (12)

1. Kestelyn PG, Cunnigham ET Jr. HIV/AIDS and blindness. Bull World Health Organ 2001;79:208-13.
2. Cunningham ET Jr. Lietman TM, Whitcher JP. Blindness: a global priority for the twenty-first century. Bull World Health Organ 2001:79:180.
3. Assefa Y, Asfawessen G, Melese A. Ocular manifestations of HIV/AIDS patients in Gondar University Hospital, north west Ethiopia. Ethiop J Health Dev 2006;20:166-9.
4. Chiou SH, Liu CY, Hsu WM, et al. Ophthalmic findings in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2000;33:45-8.
5. Biswas J, Madhavan HN, George AE, et al. Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center Am J Ophthalmol 2000;129:9-15.
6. World Health Organization. Magnitude and causes of visual impairment. In: WHO international statistical classification of diseases, injuries and causes of death. 10th revision. Geneva: World Health Organization, 2004.
7. Freeman WR, Chen A, Henderly DE, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 1989;107:229-35.
8. Akduman L, Feiner MA, Olk RJ, et al. Macular ischaemia as a cause of decreased vision in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol 1997;124:699-702.
9. Roth DB, McCabe CM, Davis JL. HIV-related occlusive vasculitis. Arch Ophthalmol 1999;117:696-8.
10. Karavellas MP, Azen SP, MacDonald JC, et al. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Betina 2001;21:1-9.
11. Arevalo JF, Mendoza AJ. Ferrettj Y. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela. Betina 2003;23:495-502.
12. Silverstein BE, Smith JH, Sykes SO, et al. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency Am J Ophthalmol 1998;125:411-15.